Amylyx Pharmaceuticals raises $135M as ALS drug heads to pivotal clinical trial July 20, 2021 Auto Bot amyotrophic lateral sclerosis, BioPharma, biopharma nl, Cambridge, Clinical Trials, deals, investing, Massachusetts, Pharma 0 An amyotrophic lateral sclerosis drug from Amylyx Pharmaceuticals is being prepared for Phase 3 clinical testing on track to begin later this quarter. To support that research, the biotech has raised $135 million in financing.